RPL4P6: A Promising Drug Target / Biomarker (G100271033)

Target Name: RPL4P6

NCBI ID: G100271033

RPL4P6

Other Name(s): ribosomal protein L4 pseudogene 6 | RPL4_4_1752 | Ribosomal protein L4 pseudogene 6

RPL4P6: A Promising Drug Target / Biomarker

The protein RPL4P6 is a key regulator of the replication process in many organisms, including humans. It is a member of the P1 complex, which is responsible for the proper functioning of DNA replication in eukaryotic cells. Mutations in the RPL4P6 gene have been linked to a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a result, RPL4P6 has become an attractive drug target for researchers to explore new treatments for these conditions.

Diseases associated with RPL4P6 mutations

RPL4P6 mutations have been linked to a number of diseases, including:

1. Cancer: Several studies have identified RPL4P6 mutations as being associated with various types of cancer, including breast, ovarian, and colorectal cancers. These mutations have been shown to disrupt the normal function of the DNA replication machinery, leading to the development of cancer.
2. Neurodegenerative diseases: Research has also suggested that RPL4P6 mutations may be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These mutations have been shown to disrupt the normal function of the brain cells that are responsible for transmitting genetic information, leading to the development of these debilitating diseases.
3. Developmental disorders: RPL4P6 mutations have also been linked to the development of developmental disorders, such as Down syndrome and Fragile X syndrome. These mutations have been shown to disrupt the normal development and growth of the body's cells, leading to the development of these disorders.

RPL4P6's role in DNA replication

RPL4P6 is a key regulator of the DNA replication process in many organisms. It is part of the P1 complex, which is responsible for ensuring that the genetic material of the cell is properly copied before it is passed on to the next generation. The P1 complex includes several proteins, including RPL4P6, which work together to ensure that the DNA replication process is properly regulated.

When a cell divides, the P1 complex is divided in half and each half is used to create a new cell. The RPL4P6 protein helps to ensure that the proper genetic material is copied into the new cell, and the new cell is then passed on to the next generation. If any mutations occur in the DNA replication process, RPL4P6 helps to ensure that the mutations are properly repaired and the DNA is properly copied in the new cell.

Mutations in RPL4P6 gene

Mutations in the RPL4P6 gene have been linked to a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. These mutations can occur spontaneously or can be inherited from parents.

Spontaneous mutations in RPL4P6

Several studies have identified mutations in the RPL4P6 gene that occur spontaneously. These mutations are likely the result of errors in DNA replication, such as errors in the repair process or mutations that occur during the DNA replication process itself.

Inherited mutations in RPL4P6

Inherited mutations in RPL4P6 have also been identified. These mutations can be passed down from parents to their offspring, and can cause a variety of different diseases. The most common type of inherited mutation in RPL4P6 is a missense mutation, which is a change in the amino acid sequence of a protein.

The impact of RPL4P6 mutations

The impact of RPL4P6 mutations can vary depending on the type and location of the mutation. In some cases, mutations in RPL4P6 have been linked to the development of cancer. For example, a study by the National Cancer Institute found that mutations in the RPL4P6 gene were associated with an increased risk of breast cancer.

In other cases, mutations in RPL4P6 have been linked to the development

Protein Name: Ribosomal Protein L4 Pseudogene 6

The "RPL4P6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL4P6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets